Effectiveness of interventions to increase uptake and completion of treatment for diabetic retinopathy in low- and middle-income countries: a rapid review protocol.

Effectiveness of interventions to increase uptake and completion of treatment for diabetic retinopathy in low- and middle-income countries: a rapid review protocol.
复制标题

在低收入和中等收入国家增加糖尿病视网膜病变治疗的接受率和完成率的干预措施的有效性:一项快速审查协议

DOI:
10.1186/s13643-020-01562-9
复制
发表时间:
2021-01-14
期刊:
影响因子:
3.7
通讯作者:
Burton M
Burton M
中科院分区:
医学4区
文献类型:
--
作者:
Bascaran C;Mwangi N;D'Esposito F;Cleland C;Gordon I;Ulloa JAL;Maswadi R;Mdala S;Ramke J;Evans JR;Burton M

文献摘要

参考文献

被引文献

相似文献

糖尿病视网膜病变引起的视力丧失可以通过治疗在很大程度上预防或延迟。患有威胁视力的糖尿病视网膜病变的患者通常被提供激光或玻璃体内注射,这通常需要一个以上的治疗周期。然而,治疗并不总是开始,或者没有完成,导致视力结果不佳。旨在改善糖尿病视网膜病变治疗的吸收或完成的干预措施可能有助于预防或延迟糖尿病患者的视力丧失。我们将检索MEDLINE、Embase、Global Health和科克伦研究注册中心,以查找报告干预措施与常规治疗相比,可改善糖尿病视网膜病变(DR)和/或糖尿病黄斑水肿(DMO)治疗成人糖尿病患者的研究。审查将包括过去20年中以英语发表的研究。我们将纳入任何研究设计,测量与DR和/或DMO的治疗吸收和完成相关的任何以下结局:(1)开始DR和/或DMO治疗的患者在被推荐的患者中的比例,(2)完成DR和/或DMO治疗的患者在被推荐的患者中的比例,(3)在开始治疗的患者中完成DR和/或DMO治疗的患者的比例,以及(4)每个患者完成的DR和/或DMO治疗轮次的数量和比例,如治疗方案所规定的。对于纳入的研究,我们还将报告可用的任何成本效益指标。两名审查员将独立筛选搜索结果。偏倚风险评估将由两名审查员完成,数据提取将由一名审查员完成,10%的论文将由第二名审查员进行验证。结果将以叙述的方式加以综合。本快速审查旨在识别和综合有关干预措施有效性的同行评议文献,以增加中低收入国家DR和/或DMO治疗的接受和完成。选择快速审查方法是为了快速综合现有证据,以支持方案执行者和决策者设计循证卫生方案和公共卫生政策,并为资源分配提供信息。OSF osf.io/h5wgr在线版本包含补充材料,可在10.1186/s13643-020-01562-9获得。
Vision loss due to diabetic retinopathy can largely be prevented or delayed through treatment. Patients with vision-threatening diabetic retinopathy are typically offered laser or intravitreal injections which often require more than one treatment cycle. However, treatment is not always initiated, or it is not completed, resulting in poor visual outcomes. Interventions aimed at improving the uptake or completion of treatment for diabetic retinopathy can potentially help prevent or delay visual loss in people with diabetes. We will search MEDLINE, Embase, Global Health and Cochrane Register of Studies for studies reporting interventions to improve the uptake of treatment for diabetic retinopathy (DR) and/or diabetic macular oedema (DMO), compared with usual care, in adults with diabetes. The review will include studies published in the last 20 years in the English language. We will include any study design that measured any of the following outcomes in relation to treatment uptake and completion for DR and/or DMO: (1) proportion of patients initiating treatment for DR and/or DMO among those to whom it is recommended, (2) proportion of patients completing treatment for DR and/or DMO among those to whom it is recommended, (3) proportion of patients completing treatment for DR and/or DMO among those initiating treatment and (4) number and proportion of DR and/or DMO rounds of treatment completed per patient, as dictated by the treatment protocol. For included studies, we will also report any measures of cost-effectiveness when available. Two reviewers will screen search results independently. Risk of bias assessment will be done by two reviewers, and data extraction will be done by one reviewer with verification of 10% of the papers by a second reviewer. The results will be synthesised narratively. This rapid review aims to identify and synthesise the peer-reviewed literature on the effectiveness of interventions to increase uptake and completion of treatment for DR and/or DMO in LMICs. The rapid review methodology was chosen in order to rapidly synthesise the available evidence to support programme implementers and policy-makers in designing evidence-based health programmes and public health policy and inform the allocation of resources. OSF osf.io/h5wgr The online version contains supplementary material available at 10.1186/s13643-020-01562-9.
DOI: 10.4103/0974-9233.80694
发表时间: 2011-04-01
影响因子: 0.6
作者:
Khandekar, Rajiv;Al Lawati, Jawad;Barakat, Nabil
通讯作者: Barakat, Nabil
DOI: 10.15171/ijhpm.2015.04
发表时间: 2015-01-01
期刊: INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT-IJHPM
影响因子: --
作者:
Poore, Sophie;Foster, Allen;Blanchet, Karl
通讯作者: Blanchet, Karl
DOI: 10.1093/heapol/czr038
发表时间: 2012-07-01
影响因子: 3.2
作者:
Jacobs, Bart;Ir, Por;Van Damme, Wim
通讯作者: Van Damme, Wim
DOI: 10.3928/23258160-20180221-06
发表时间: 2018-03-01
影响因子: 1
作者:
Jansen, Michael E.;Krambeer, Chelsey J.;Singer, Michael A.
通讯作者: Singer, Michael A.
DOI: 10.1371/journal.pone.0129361
发表时间: 2015
期刊: PloS one
影响因子: 3.7
作者:
Gohil R;Crosby-Nwaobi R;Forbes A;Burton B;Hykin P;Sivaprasad S
通讯作者: Sivaprasad S